EP2210585A1 — SPRM pharmaceutical compositions methods of treatment using them
Assigned to Exelgyn · Expires 2010-07-28 · 16y expired
What this patent protects
The invention aims at providing novel compositions comprising Selective Progesterone Receptor Modulator (SPRM) and novel methods of treatment using them, which have the ability to prevent the intake of the composition by the patient in an abortive amount and avoid their misuse.
USPTO Abstract
The invention aims at providing novel compositions comprising Selective Progesterone Receptor Modulator (SPRM) and novel methods of treatment using them, which have the ability to prevent the intake of the composition by the patient in an abortive amount and avoid their misuse.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.